Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan

被引:37
|
作者
Khan, Imran [1 ]
Ahmad, Nafees [1 ]
Khan, Shereen [2 ]
Muhammad, Shafi [3 ]
Khan, Shabir Ahmad [4 ]
Ahmad, Izaz [5 ]
Khan, Asad [1 ]
Gulalai [1 ]
Atif, Muhammad [6 ]
机构
[1] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Pakistan
[2] Bolan Med Coll Quetta, Quetta, Pakistan
[3] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharmacognosy, Quetta, Pakistan
[4] Univ Baluchistan Quetta, Ctr Excellence Vaccinol & Biotechnol, Quetta, Pakistan
[5] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[6] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Pakistan
关键词
Baluchistan; Body weight; Death; MDR-TB; Ofloxacin; RISK-FACTORS; PROGRAMMATIC MANAGEMENT; LATENT TUBERCULOSIS; RATES; PREVALENCE; PREDICTORS; DEATH;
D O I
10.1016/j.jiph.2019.04.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Evaluating treatment outcomes of a cohort of patients is an effective way for analyzing the effectiveness of a program. Information regarding drug resistance pattern, detailed management, treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant (MDR-TB) patients is missing from Baluchistan province of Pakistan. Methods This study was carried out at Programmatic Management of Drug Resistant TB unit at Fatimah Jinnah General and Chest Hospital Quetta. All eligible 186 MDR-TB patients enrolled at the study site from January 1, 2012 to April 30, 2016 were retrospectively followed until the treatment outcomes were reported. Data was abstracted through a standardized data collection form and analysed by SPSS 20. Multivariate binary logistic regression (MVBLR) analysis was used to evaluate factors associated with i) death and treatment failure and ii) lost to follow up. A p-value of <0.05 was considered statistically significant. Results The study participants were resistant to a median of four drugs (range 28) with majority being resistant to any second-line anti-TB drug (SLD) (55.5%). Among SLD, resistance was highest for ofloxacin (52.2%). The study site had an overall treatment success rate of 71.6%. A total of 129 (69.4%) patients were cured, four (2.2%) completed treatment, 37 died (19.9%), 14 (7.5%) were lost to follow up and two (1.1%) were declared treatment failures. In MVBLR analysis, patients age of >40 years (OR?=?4.249, p-value?=?0.001) had statistically significant positive and baseline body weight of >40?kg (OR?=?0.256, p-value?=?0.002) had statistically significant negative association with death and treatment failure. No factor had statistical significant association with lost to follow up. Conclusion Overall treatment success rate was promising but did not achieve the target success rate (>75%) set by World Health Organization. It can be further improved by paying special attention and providing enhanced management to the patients with risk factors for unsuccessful outcomes. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgg/licensesiby-nc-nd/4.0/).
引用
收藏
页码:809 / 815
页数:7
相关论文
共 50 条
  • [1] Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients
    Muhammad Atif
    Arslan Bashir
    Nafees Ahmad
    Razia Kaneez Fatima
    Sehar Saba
    Shane Scahill
    BMC Infectious Diseases, 17
  • [2] Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients
    Atif, Muhammad
    Bashir, Arslan
    Ahmad, Nafees
    Fatima, Razia Kaneez
    Saba, Sehar
    Scahill, Shane
    BMC INFECTIOUS DISEASES, 2017, 17
  • [3] Risk factors associated with unsuccessful tuberculosis treatment outcomes in Hunan Province, China
    Gilmour, Beth
    Xu, Zuhui
    Bai, Liqiong
    Alene, Kefyalew Addis
    Clements, Archie C. A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (03) : 290 - 299
  • [4] Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis
    Azee, Adeboye
    Ndege, James
    Mutambayi, Ruffin
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2018, 7 (04) : 347 - 354
  • [5] Treatment Outcomes Associated with Multidrug-resistant Tuberculosis
    Gupta, Nitin
    Jorwal, Pankaj
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2018, 10 (03) : 125 - 128
  • [6] Outcomes of Bedaquiline Treatment in Patients with Multidrug Resistant Tuberculosis
    Mbuagbaw, Lawrence
    Guglielmetti, Lorenzo
    Hewison, Catherine
    Bakare, Nyasha
    Bastard, Mathieu
    Caumes, Eric
    Frechet-Jachym, Mathilde
    Robert, Jerome
    Veziris, Nicolas
    Khachatryan, Naira
    Kotrikadze, Tinatin
    Hayrapetyan, Armen
    Avaliani, Zaza
    Schunemann, Holger J.
    Lienhardt, Christian
    EMERGING INFECTIOUS DISEASES, 2019, 25 (05) : 936 - 943
  • [7] Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
    Kefyalew Addis Alene
    Hengzhong Yi
    Kerri Viney
    Emma S. McBryde
    Kunyun Yang
    Liqiong Bai
    Darren J. Gray
    Archie C. A. Clements
    Zuhui Xu
    BMC Infectious Diseases, 17
  • [8] Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
    Alene, Kefyalew Addis
    Yi, Hengzhong
    Viney, Kerri
    McBryde, Emma S.
    Yang, Kunyun
    Bai, Liqiong
    Gray, Darren J.
    Clements, Archie C. A.
    Xu, Zuhui
    BMC INFECTIOUS DISEASES, 2017, 17
  • [9] Treatment outcomes among patients with multidrug-resistant tuberculosis
    Munsiff, Sonal S.
    LANCET INFECTIOUS DISEASES, 2010, 10 (04): : 215 - 215
  • [10] Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients
    Brode, Sarah K.
    Varadi, Robert
    McNamee, Jane
    Malek, Nina
    Stewart, Sharon
    Jamieson, Frances B.
    Avendano, Monica
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (02) : 97 - 102